Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial (Q43804989)

27 November 2017

title

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial (English)

1 reference

27 November 2017

0 references

1 reference

1 reference

1 reference

27 November 2017

M W Büchler

1 reference

27 November 2017

H Friess

1 reference

27 November 2017

J P Neoptolemos

1 reference

27 November 2017

J A Dunn

1 reference

27 November 2017

D D Stocken

1 reference

27 November 2017

J Almond

1 reference

27 November 2017

K Link

1 reference

27 November 2017

H Beger

1 reference

27 November 2017

C Bassi

1 reference

27 November 2017

P Pederzoli

1 reference

27 November 2017

C Dervenis

1 reference

27 November 2017

L Fernandez-Cruz

1 reference

27 November 2017

F Lacaine

1 reference

27 November 2017

A Pap

1 reference

27 November 2017

D Spooner

1 reference

27 November 2017

D J Kerr

1 reference

27 November 2017

European Study Group for Pancreatic Cancer

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

27 November 2017

1 reference

inferred from page(s)

published in

The Lancet

1 reference

27 November 2017

volume

358

1 reference

27 November 2017

issue

9293

1 reference

27 November 2017

page(s)

1576-1585

1 reference

Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Relationship between hospital volume and late survival after pancreaticoduodenectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Recurrence after resection for ductal adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Patterns of failure after curative resection of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Standard Kausch-Whipple pancreatoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Intraoperative and postoperative radiotherapy in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906651-X

7 January 2021

10.1016/S0140-6736(01)06651-X

Identifiers

DOI

1 reference

27 November 2017

1 reference